 Abacavir/lamivudine/zidovudine

Abacavir/lamivudine/zidovudine, sold under the brand name Trizivir, is a medication for HIV/AIDS.It is a fixed dose combination of three reverse transcriptase inhibitors patented by GlaxoSmithKline and marketed by a joint venture with Pfizer, ViiV Healthcare